Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking

Nitazoxanide has been investigated for colorectal cancer and breast cancer. However, its molecular targets and pathways have not yet been explored for hepatocellular carcinoma (HCC) treatment. Utilizing a network pharmacology approach, nitazoxanide’s potential targets and molecular pathways for HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shakeel Ahmad, Lee, Terence Kin Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358010/
https://www.ncbi.nlm.nih.gov/pubmed/35959427
http://dx.doi.org/10.3389/fphar.2022.968148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358010/
https://www.ncbi.nlm.nih.gov/pubmed/35959427
http://dx.doi.org/10.3389/fphar.2022.968148

Ejemplares similares